open access

Vol 68, No 3 (2017)
Original papers
Published online: 2017-06-21
Submitted: 2016-03-01
Accepted: 2016-03-29
Get Citation

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma

Dorota Kula, Michał Kalemba, Zbigniew Puch, Joanna Polańska, Michał Świerniak, Dagmara Rusinek, Jadwiga Żebracka-Gala, Małgorzata Kowalska, Daria Handkiewicz-Junak, Monika Kowal, Tomasz Tyszkiewicz, Ewelina Piasna, Agnieszka Czarniecka, Agnieszka Pawlaczek, Jolanta Krajewska, Sylwia Szpak-Ulczok, Barbara Jarząb
DOI: 10.5603/EP.2017.0021
·
Endokrynologia Polska 2017;68(3):283-289.

open access

Vol 68, No 3 (2017)
Original papers
Published online: 2017-06-21
Submitted: 2016-03-01
Accepted: 2016-03-29

Abstract

Introduction: Papillary thyroid cancer (PTC) shows familial occurrence, and some susceptibility single nucleotide polymorphisms (SNPs) have been identified in FOXE1 and near the NKX2-1 locus. The aim of our study was to analyse the association of PTC risk with SNPs in FOXE1 (rs965513, rs1867277, rs1443434) and near the NKX2-1 locus (rs944289) in a Polish population, and, in the second step, the interac­tion between SNPs and patient-related factors (age at diagnosis and gender).

Material and methods: A total of 2243 DNA samples from PTC patients and 1160 controls were included in the study. The SNP analysis was performed with the allelic discrimination technique.

Results: There were significant associations of all SNPs with PTC (rs965513 odds ratio [OR] = 1.72, p = 8 × 10-7; rs1867277 OR = 1.59, p = 1 × 10-6; rs1443434 OR = 1.53, p = 1 × 10-5; rs944289 OR = 1.52, p = 4 × 10-5). Logistic regression analysis revealed an increased PTC risk in the interaction of rs944289 with age at diagnosis (OR = 1.01 per year, p = 6 × 10-4) and a decreased PTC risk in the interaction of male gender with the GGT FOXE1 protective haplotype (OR = 0.69, p = 0.01).

Conclusions: the association between PTC and all analysed SNPs was confirmed. It was also shown that patient-related factors modify the predisposition to PTC by increasing the risk for rs944289 per year of age, and by enhancing the protective effect of the FOXE1 GGT haplotype in men.

Abstract

Introduction: Papillary thyroid cancer (PTC) shows familial occurrence, and some susceptibility single nucleotide polymorphisms (SNPs) have been identified in FOXE1 and near the NKX2-1 locus. The aim of our study was to analyse the association of PTC risk with SNPs in FOXE1 (rs965513, rs1867277, rs1443434) and near the NKX2-1 locus (rs944289) in a Polish population, and, in the second step, the interac­tion between SNPs and patient-related factors (age at diagnosis and gender).

Material and methods: A total of 2243 DNA samples from PTC patients and 1160 controls were included in the study. The SNP analysis was performed with the allelic discrimination technique.

Results: There were significant associations of all SNPs with PTC (rs965513 odds ratio [OR] = 1.72, p = 8 × 10-7; rs1867277 OR = 1.59, p = 1 × 10-6; rs1443434 OR = 1.53, p = 1 × 10-5; rs944289 OR = 1.52, p = 4 × 10-5). Logistic regression analysis revealed an increased PTC risk in the interaction of rs944289 with age at diagnosis (OR = 1.01 per year, p = 6 × 10-4) and a decreased PTC risk in the interaction of male gender with the GGT FOXE1 protective haplotype (OR = 0.69, p = 0.01).

Conclusions: the association between PTC and all analysed SNPs was confirmed. It was also shown that patient-related factors modify the predisposition to PTC by increasing the risk for rs944289 per year of age, and by enhancing the protective effect of the FOXE1 GGT haplotype in men.

Get Citation

Keywords

SNP; carcinoma papillare; age at diagnosis; gender

About this article
Title

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma

Journal

Endokrynologia Polska

Issue

Vol 68, No 3 (2017)

Pages

283-289

Published online

2017-06-21

DOI

10.5603/EP.2017.0021

Bibliographic record

Endokrynologia Polska 2017;68(3):283-289.

Keywords

SNP
carcinoma papillare
age at diagnosis
gender

Authors

Dorota Kula
Michał Kalemba
Zbigniew Puch
Joanna Polańska
Michał Świerniak
Dagmara Rusinek
Jadwiga Żebracka-Gala
Małgorzata Kowalska
Daria Handkiewicz-Junak
Monika Kowal
Tomasz Tyszkiewicz
Ewelina Piasna
Agnieszka Czarniecka
Agnieszka Pawlaczek
Jolanta Krajewska
Sylwia Szpak-Ulczok
Barbara Jarząb

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl